‘Contingency on contingency’: Judge won’t halt IP dispute over Abilify generic
The Commonwealth has lost its bid to pause a long-running dispute over a generic form of brand drug Abilify while the High Court hears a different generic drug battle.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
